[Correspondence] Optimal imaging before local therapy of colorectal liver metastases

February, 02, 2024 | Select Oncology Journal Articles

We read with interest, Burak Görgec and colleagues’ study,1 in which they report a change in the local treatment plan in patients with colorectal liver metastases based on liver contrast-enhanced MRI in 92 (31%) of 298 patients, with respect to the findings based on contrast-enhanced CT. Changes were made for 40 (13%) patients requiring more extensive local therapy, 11 (4%) patients requiring less extensive local therapy, and 34 (11%) patients in whom the indication for curative-intent local therapy was revoked, including 26 (9%) patients with too extensive disease, and eight (3%) patients with benign lesions on liver contrast-enhanced MRI.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy